Synthesis and Biological Evaluation of Genistein-IR783 Conjugate: Cancer Cell Targeted Delivery in MCF-7 for Superior Anti-Cancer Therapy
Abstract
:1. Introduction
2. Results
2.1. Chemistry
2.2. In Vitro Cell Uptake Assay
2.3. Mechanism-Based Cellular Uptake of Conjugate
2.4. In Vitro Cell Viability Studies.
2.5. In Vivo Targeting Assay in Mouse Bearing Breast Tumor Xenograft.
3. Discussion
4. Conclusions
5. Materials and Methods
5.1. General Chemisty
5.2. Synthesis and Characterization of Genistein-IR783 Conjugate
5.3. Spectroscopic Evaluation of Conjugate (UV-VIS and Fluorescence).
5.3.1. UV-VIS Spectra
5.3.2. Fluorescence Spectra
5.3.3. Partition Coefficient
5.4. Cellular Uptake Assays
5.5. Mechanistic Cellular Uptake Assays
5.5.1. OATPs Inhibition
5.5.2. Macropinocytosis Inhibition
5.6. In Vitro Cell Viability Assays
5.7. In Vivo MCF-7 Breast Cancer Xenograft Bearing Mice Model
5.8. In Vivo NIRF Imaging of Mice Bearing MCF-7 Breast Tumors
5.9. Statistical Analysis
Supplementary Materials
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Abotaleb, M.; Samuel, S.M.; Varghese, E.; Varghese, S.; Kubatka, P.; Liskova, A.; Büsselberg, D. Flavonoids in Cancer and Apoptosis. Cancers 2018, 11, 28. [Google Scholar] [CrossRef] [PubMed]
- Kabała-Dzik, A.; Rzepecka-Stojko, A.; Kubina, R.; Iriti, M.; Wojtyczka, R.D.; Buszman, E.; Stojko, J. Flavonoids, bioactive components of propolis, exhibit cytotoxic activity and induce cell cycle arrest and apoptosis in human breast cancer cells MDA-MB-231 and MCF-7 – a comparative study. Cell. Mol. Boil. 2018, 64, 1–10. [Google Scholar] [CrossRef]
- Zhang, H.W.; Hu, J.J.; Fu, R.Q.; Liu, X.; Zhang, Y.H.; Li, J.; Liu, L.; Li, Y.N.; Deng, Q.; Luo, Q.S.; et al. Flavonoids inhibit cell proliferation and induce apoptosis and autophagy through downregulation of PI3Kgamma mediated PI3K/AKT/mTOR/p70S6K/ULK signaling pathway in human breast cancer cells. Sci. Rep. 2018, 8, 11255. [Google Scholar] [CrossRef] [PubMed]
- Ho, M.X.; Poon, C.C.W.; Wong, K.C.; Qiu, Z.C.; Wong, M.S. Icariin, but Not Genistein, Exerts Osteogenic and Anti-apoptotic Effects in Osteoblastic Cells by Selective Activation of Non-genomic ERalpha Signaling. Front Pharmacol. 2018, 9, 474. [Google Scholar] [CrossRef]
- Wang, L.; Waltenberger, B.; Pferschy-Wenzig, E.M.; Blunder, M.; Liu, X.; Malainer, C.; Blazevic, T.; Schwaiger, S.; Rollinger, J.M.; Heiss, E.H.; et al. Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARgamma): A review. Biochem. Pharmacol. 2014, 92, 73–89. [Google Scholar] [CrossRef]
- Xu, L.; Liu, J.T.; Li, K.; Wang, S.Y.; Xu, S. Genistein inhibits Ang II-induced CRP and MMP-9 generations via the ER-p38/ERK1/2-PPARgamma-NF-kappaB signaling pathway in rat vascular smooth muscle cells. Life Sci. 2019, 216, 140–146. [Google Scholar] [CrossRef]
- Mizushina, Y.; Shiomi, K.; Kuriyama, I.; Takahashi, Y.; Yoshida, H. Inhibitory effects of a major soy isoflavone, genistein, on human DNA topoisomerase II activity and cancer cell proliferation. Int. J. Oncol. 2013, 43, 1117–1124. [Google Scholar] [CrossRef]
- Varinska, L.; Gal, P.; Mojžišová, G.; Mirossay, L.; Mojžiš, J. Soy and Breast Cancer: Focus on Angiogenesis. Int. J. Mol. Sci. 2015, 16, 11728–11749. [Google Scholar] [CrossRef]
- Shehata, E.M.; Elnaggar, Y.S.; Galal, S.; Abdallah, O.Y. Self-emulsifying phospholipid pre-concentrates (SEPPs) for improved oral delivery of the anti-cancer genistein: Development, appraisal and ex-vivo intestinal permeation. Int. J. Pharm. 2016, 511, 745–756. [Google Scholar] [CrossRef]
- Yang, Z.; Kulkarni, K.; Zhu, W.; Hu, M. Bioavailability and pharmacokinetics of genistein: Mechanistic studies on its ADME. Anti-Cancer Agents Med. Chem. 2012, 12, 1264–1280. [Google Scholar] [CrossRef]
- Lambert, J.M.; Berkenblit, A. Antibody–Drug Conjugates for Cancer Treatment. Annu. Rev. Med. 2018, 69, 191–207. [Google Scholar] [CrossRef] [PubMed]
- Sau, S.; Alsaab, H.O.; Bhise, K.; Alzhrani, R.; Nabil, G.; Iyer, A.K. Multifunctional nanoparticles for cancer immunotherapy: A groundbreaking approach for reprogramming malfunctioned tumor environment. J. Control. Release 2018, 274, 24–34. [Google Scholar] [CrossRef] [PubMed]
- Trail, P.A.; Dubowchik, G.M.; Lowinger, T.B. Antibody drug conjugates for treatment of breast cancer: Novel targets and diverse approaches in ADC design. Pharmacol. Ther. 2018, 181, 126–142. [Google Scholar] [CrossRef] [PubMed]
- Danciu, C.; Berkó, S.; Varju, G.; Balázs, B.; Kemény, L.; Németh, I.B.; Cioca, A.; Petruș, A.; Dehelean, C.; Cosmin, C.I.; et al. The Effect of Electroporation of a Lyotroic Liquid Crystal Genistein-Based Formulation in the Recovery of Murine Melanoma Lesions. Int. J. Mol. Sci. 2015, 16, 15425–15441. [Google Scholar] [CrossRef]
- Kim, H.; Choi, J.-S.; Kim, K.S.; Yang, J.-A.; Joo, C.-K.; Hahn, S.K. Flt1 peptide–hyaluronate conjugate micelle-like nanoparticles encapsulating genistein for the treatment of ocular neovascularization. Acta Biomater. 2012, 8, 3932–3940. [Google Scholar] [CrossRef]
- Pham, J.; Brownlow, B.; Elbayoumi, T. Mitochondria-Specific Pro-Apoptotic Activity of Genistein Lipidic Nanocarriers. Mol. Pharm. 2013, 10, 3789–3800. [Google Scholar] [CrossRef]
- Pham, J.; Grundmann, O.; Elbayoumi, T. Mitochondriotropic Nanoemulsified Genistein-Loaded Vehicles for Cancer Therapy. Adv. Struct. Saf. Stud. 2015, 1265, 85–101. [Google Scholar]
- Phan, V.; Walters, J.; Brownlow, B.; Elbayoumi, T. Enhanced cytotoxicity of optimized liposomal genistein via specific induction of apoptosis in breast, ovarian and prostate carcinomas. J. Drug Target 2013, 21, 1001–1011. [Google Scholar] [CrossRef]
- Ruoslahti, E. Tumor penetrating peptides for improved drug delivery. Adv. Drug Deliv. Rev. 2017, 110, 3–12. [Google Scholar] [CrossRef]
- Adams, B.D.; Parsons, C.; Walker, L.; Zhang, W.C.; Slack, F.J. Targeting noncoding RNAs in disease. J. Clin. Investig. 2017, 127, 761–771. [Google Scholar] [CrossRef]
- Wang, Y.; Liu, T.; Zhang, E.; Luo, S.; Tan, X.; Shi, C. Preferential accumulation of the near infrared heptamethine dye IR-780 in the mitochondria of drug-resistant lung cancer cells. Biomaterials 2014, 35, 4116–4124. [Google Scholar] [CrossRef] [PubMed]
- Yang, X.; Shi, C.; Tong, R.; Qian, W.; Zhau, H.E.; Wang, R.; Zhu, G.; Cheng, J.; Yang, V.W.; Cheng, T.; et al. Near IR heptamethine cyanine dye-mediated cancer imaging. Clin. Cancer Res. 2010, 16, 2833–2844. [Google Scholar] [CrossRef] [PubMed]
- Shi, C.; Wu, J.B.; Chu, G.C.-Y.; Li, Q.; Wang, R.; Zhang, C.; Zhang, Y.; Kim, H.L.; Wang, J.; Zhau, H.E.; et al. Heptamethine carbocyanine dye-mediated near-infrared imaging of canine and human cancers through the HIF-1α/OATPs signaling axis. Oncotarget 2014, 5, 10114–10126. [Google Scholar] [CrossRef] [PubMed]
- Xiao, L.; Zhang, Y.; Yue, W.; Xie, X.; Wang, J.-P.; Chordia, M.D.; Chung, L.W.; Pan, D. Heptamethine Cyanine Based 64Cu - PET Probe PC-1001 for Cancer Imaging: Synthesis and In Vivo Evaluation. Nucl. Med. Boil. 2013, 40, 351–360. [Google Scholar] [CrossRef] [PubMed]
- Zhang, Y.; Xiao, L.; Popović, K.; Xie, X.; Chordia, M.D.; Chung, L.W.; Williams, M.B.; Yue, W.; Pan, D. Novel Cancer-Targeting SPECT/NIRF Dual-modality Imaging Probe 99mTc -PC-1007: Synthesis and Biological Evaluation. Bioorganic Med. Chem. Lett. 2013, 23, 6350–6354. [Google Scholar] [CrossRef]
- Wu, J.B.; Lin, T.-P.; Gallagher, J.D.; Kushal, S.; Chung, L.W.K.; Zhau, H.E.; Olenyuk, B.Z.; Shih, J.C. Monoamine Oxidase A Inhibitor–Near-Infrared Dye Conjugate Reduces Prostate Tumor Growth. J. Am. Chem. Soc. 2015, 137, 2366–2374. [Google Scholar] [CrossRef]
- Jiang, Z.; Pflug, K.M.; Usama, S.M.; Kuai, D.; Yan, X.; Sitcheran, R.; Burgess, K.; Yan, D.X. Cyanine-Gemcitabine Conjugates as Targeted Theranostic Agents for Glioblastoma Tumor Cells. J. Med. Chem. 2019, 62, 9236–9245. [Google Scholar] [CrossRef]
- Lv, Q.; Yang, X.; Wang, M.; Yang, J.; Qin, Z.; Kan, Q.; Zhang, H.; Wang, Y.; Wang, D.; He, Z. Mitochondria-targeted prostate cancer therapy using a near-infrared fluorescence dye–monoamine oxidase A inhibitor conjugate. J. Control. Release 2018, 279, 234–242. [Google Scholar] [CrossRef]
- Lv, Q.; Wang, D.; Yang, Z.; Yang, J.; Zhang, R.; Yang, X.; Wang, M.; Wang, Y. Repurposing antitubercular agent isoniazid for treatment of prostate cancer. Biomater. Sci. 2019, 7, 296–306. [Google Scholar] [CrossRef]
- Yang, X.-G.; Mou, Y.-H.; Wang, Y.-J.; Wang, J.; Li, Y.-Y.; Kong, R.-H.; Ding, M.; Wang, D.; Guo, C. Design, Synthesis, and Evaluation of Monoamine Oxidase A Inhibitors—Indocyanine Dyes Conjugates as Targeted Antitumor Agents. Molecules 2019, 24, 1400. [Google Scholar] [CrossRef]
- Yi, X.; Zhang, J.; Yan, F.; Lu, Z.; Huang, J.; Pan, C.; Yuan, J.; Zheng, W.; Zhang, K.; Wei, D.; et al. Synthesis of IR-780 dye-conjugated abiraterone for prostate cancer imaging and therapy. Int. J. Oncol. 2016, 49, 1911–1920. [Google Scholar] [CrossRef] [PubMed]
- Yang, Z.; Lee, J.H.; Jeon, H.M.; Han, J.H.; Park, N.; He, Y.; Lee, H.; Hong, K.S.; Kang, C.; Kim, J.S. Folate-Based Near-Infrared Fluorescent Theranostic Gemcitabine Delivery. J. Am. Chem. Soc. 2013, 135, 11657–11662. [Google Scholar] [CrossRef] [PubMed]
- Tang, L.; Singh, R.; Liu, Z.; Hu, M. Structure and Concentration Changes Affect Characterization of UGT Isoform-Specific Metabolism of Isoflavones. Mol. Pharm. 2009, 6, 1466–1482. [Google Scholar] [CrossRef] [PubMed]
- Bouteiller, C.; Clavé, G.; Bernardin, A.; Chipon, B.; Massonneau, M.; Renard, P.-Y.; Romieu, A. Novel Water-Soluble Near-Infrared Cyanine Dyes: Synthesis, Spectral Properties, and Use in the Preparation of Internally Quenched Fluorescent Probes. Bioconjugate Chem. 2007, 18, 1303–1317. [Google Scholar] [CrossRef] [PubMed]
- Harrison, V.S.R.; Carney, C.E.; MacRenaris, K.W.; Waters, E.A.; Meade, T.J. Multimeric Near IR–MR Contrast Agent for Multimodal In Vivo Imaging. J. Am. Chem. Soc. 2015, 137, 9108–9116. [Google Scholar] [CrossRef] [PubMed]
- Zhang, E.; Luo, S.; Tan, X.; Shi, C. Mechanistic study of IR-780 dye as a potential tumor targeting and drug delivery agent. Biomaterials 2014, 35, 771–778. [Google Scholar] [CrossRef]
- Flanagan, J.H.; Khan, S.H.; Menchen, S.; Soper, S.A.; Hammer, R.P. Functionalized Tricarbocyanine Dyes as Near-Infrared Fluorescent Probes for Biomolecules. Bioconjugate Chem. 1997, 8, 751–756. [Google Scholar] [CrossRef]
- Qiang, X.; Sang, Z.; Yuan, W.; Li, Y.; Liu, Q.; Bai, P.; Shi, Y.; Ang, W.; Tan, Z.; Deng, Y. Design, synthesis and evaluation of genistein-O-alkylbenzylamines as potential multifunctional agents for the treatment of Alzheimer’s disease. Eur. J. Med. Chem. 2014, 76, 314–331. [Google Scholar] [CrossRef]
- McMahon, H.T.; Boucrot, E. Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat. Rev. Mol. Cell Boil. 2011, 12, 517–533. [Google Scholar] [CrossRef]
- Doherty, G.J.; McMahon, H.T. Mechanisms of Endocytosis. Annu. Rev. Biochem. 2009, 78, 857–902. [Google Scholar] [CrossRef] [Green Version]
- Yue, W.; Wang, J.P.; Hamilton, C.J.; Demers, L.M.; Santen, R.J. In situ aromatization enhances breast tumor estradiol levels and cellular proliferation. Cancer Res. 1998, 58, 927–932. [Google Scholar] [PubMed]
- Russo, M.; Russo, G.L.; Daglia, M.; Kasi, P.D.; Ravi, S.; Nabavi, S.F.; Nabavi, S.M. Understanding genistein in cancer: The “good” and the “bad” effects: A review. Food Chem. 2016, 196, 589–600. [Google Scholar] [CrossRef] [PubMed]
- Popiołkiewicz, J.; Polkowski, K.; Skierski, J.S.; Mazurek, A.P. In vitro toxicity evaluation in the development of new anticancer drugs—genistein glycosides. Cancer Lett. 2005, 229, 67–75. [Google Scholar] [CrossRef] [PubMed]
- Yi, X.; Yan, F.; Wang, F.; Qin, W.; Wu, G.; Yang, X.; Shao, C.; Chung, L.W.; Yuan, J. IR-780 Dye for Near-Infrared Fluorescence Imaging in Prostate Cancer. Med. Sci. Monit. 2015, 21, 511–517. [Google Scholar] [PubMed] [Green Version]
- Li, H.-Q.; Ge, H.-M.; Chen, Y.-X.; Xu, C.; Shi, L.; Ding, H.; Zhu, H.-L.; Tan, R.-X. Synthesis and Cytotoxic Evaluation of a Series of Genistein Derivatives. Chem. Biodivers. 2006, 3, 463–472. [Google Scholar] [CrossRef] [PubMed]
- Wlcek, K.; Svoboda, M.; Sellner, F.; Krupitza, G.; Jaeger, W.; Thalhammer, T. Altered expression of organic anion transporter polypeptide (OATP) genes in human breast carcinoma. Cancer Boil. Ther. 2008, 7, 1450–1455. [Google Scholar] [CrossRef] [Green Version]
- Pavese, J.M.; Farmer, R.L.; Bergan, R.C. Inhibition of cancer cell invasion and metastasis by genistein. Cancer Metastasis Rev. 2010, 29, 465–482. [Google Scholar] [CrossRef] [Green Version]
- Guan, Y.; Zhang, Y.; Xiao, L.; Li, J.; Wang, J.P.; Chordia, M.D.; Liu, Z.Q.; Chung, L.W.; Yue, W.; Pan, D. Improving Therapeutic Potential of Farnesylthiosalicylic Acid: Tumor Specific Delivery via Conjugation with Heptamethine Cyanine Dye. Mol. Pharm. 2017, 14, 1–13. [Google Scholar] [CrossRef]
- Masamura, S.; Santner, S.J.; Heitjan, D.F.; Santen, R.J. Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells. J. Clin. Endocrinol. Metab. 1995, 80, 2918–2925. [Google Scholar]
- Santen, R.J.; Song, R.X.; Zhang, Z.; Kumar, R.; Jeng, M.-H.; Masamura, A.; Lawrence, J.; Berstein, L.; Yue, W. Long-term estradiol deprivation in breast cancer cells up-regulates growth factor signaling and enhances estrogen sensitivity. Endocr. -Relat. Cancer 2005, 12, S61–S73. [Google Scholar] [CrossRef]
- Yue, W.; Wang, J.; Li, Y.; Fan, P.; Santen, R.J. Farnesylthiosalicylic acid blocks mammalian target of rapamycin signaling in breast cancer cells. Int. J. Cancer 2005, 117, 746–754. [Google Scholar] [CrossRef] [PubMed]
- Xiao, L.; Zhang, Y.; Berr, S.S.; Chordia, M.D.; Pramoonjago, P.; Pu, L.; Pan, D. A novel near-infrared fluorescence imaging probe for in vivo neutrophil tracking. Mol. Imaging 2012, 11, 372–382. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Sample Availability: Sample of the conjugate 4 is available from the authors. |
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Guan, Y.; Zhang, Y.; Zou, J.; Huang, L.-P.; Chordia, M.D.; Yue, W.; Wu, J.-J.; Pan, D.-F. Synthesis and Biological Evaluation of Genistein-IR783 Conjugate: Cancer Cell Targeted Delivery in MCF-7 for Superior Anti-Cancer Therapy. Molecules 2019, 24, 4120. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules24224120
Guan Y, Zhang Y, Zou J, Huang L-P, Chordia MD, Yue W, Wu J-J, Pan D-F. Synthesis and Biological Evaluation of Genistein-IR783 Conjugate: Cancer Cell Targeted Delivery in MCF-7 for Superior Anti-Cancer Therapy. Molecules. 2019; 24(22):4120. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules24224120
Chicago/Turabian StyleGuan, Yang, Yi Zhang, Juan Zou, Li-Ping Huang, Mahendra D. Chordia, Wei Yue, Jin-Jun Wu, and Dong-Feng Pan. 2019. "Synthesis and Biological Evaluation of Genistein-IR783 Conjugate: Cancer Cell Targeted Delivery in MCF-7 for Superior Anti-Cancer Therapy" Molecules 24, no. 22: 4120. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules24224120